128 related articles for article (PubMed ID: 32291737)
21. Surgical extent of central lymph node dissection in clinically node-negative papillary thyroid cancer.
Kim WW; Park HY; Jung JH
Head Neck; 2013 Nov; 35(11):1616-20. PubMed ID: 23322499
[TBL] [Abstract][Full Text] [Related]
22. Central Lymph Node Dissection Improves Lymph Node Clearance in Papillary Thyroid Cancer Patients with Lateral Neck Metastases, Even after Prior Total Thyroidectomy.
Hall CM; Snyder SK; Lairmore TC
Am Surg; 2018 Apr; 84(4):531-536. PubMed ID: 29712601
[TBL] [Abstract][Full Text] [Related]
23. Sonographic features of cervical lymph nodes after thyroidectomy for papillary thyroid carcinoma.
Kim DW; Choo HJ; Lee YJ; Jung SJ; Eom JW; Ha TK
J Ultrasound Med; 2013 Jul; 32(7):1173-80. PubMed ID: 23804339
[TBL] [Abstract][Full Text] [Related]
24. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
25. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
26. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
27. Lymphovascular invasion is associated with survival for papillary thyroid cancer.
Pontius LN; Youngwirth LM; Thomas SM; Scheri RP; Roman SA; Sosa JA
Endocr Relat Cancer; 2016 Jul; 23(7):555-62. PubMed ID: 27317633
[TBL] [Abstract][Full Text] [Related]
28. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
30. Can we rely on pathologic parameters to define conservative treatment of papillary thyroid carcinoma?
Paessler M; Kreisel FH; LiVolsi VA; Akslen LA; Baloch ZW
Int J Surg Pathol; 2002 Oct; 10(4):267-72. PubMed ID: 12490976
[TBL] [Abstract][Full Text] [Related]
31. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer.
Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z
Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841
[TBL] [Abstract][Full Text] [Related]
32. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and clinical indication of metastasis to lymph nodes posterior to right recurrent laryngeal nerve in papillary thyroid carcinoma: a single-center study in China.
Pinyi Z; Bin Z; Jianlong B; Yao L; Weifeng Z
Head Neck; 2014 Sep; 36(9):1335-42. PubMed ID: 23955992
[TBL] [Abstract][Full Text] [Related]
34. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
35. [Predictors of level V lymphatic metastasis in papillary thyroid carcinoma].
Chen R; Wei T; Li ZH; Gong RX; Zhu JQ
Zhonghua Wai Ke Za Zhi; 2012 Jul; 50(7):625-8. PubMed ID: 22943994
[TBL] [Abstract][Full Text] [Related]
36. Recurrence pattern after conservative surgery for papillary thyroid carcinoma.
Kobayashi K; Takenouchi S; Mitani H; Yoshida T
Auris Nasus Larynx; 2014 Dec; 41(6):548-51. PubMed ID: 24976169
[TBL] [Abstract][Full Text] [Related]
37. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
Nie X; Tan Z; Ge M
BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029
[TBL] [Abstract][Full Text] [Related]
38. Primary tumour characteristics predict the invasiveness of lymph node metastases in papillary thyroid carcinoma patients.
Lee HS; Park C; Kim SW; Song JW; Chun BK; Park TJ; Hong JC; Lee KD
J Laryngol Otol; 2016 Mar; 130(3):302-8. PubMed ID: 26669829
[TBL] [Abstract][Full Text] [Related]
39. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer.
Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B
Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis.
Cho JG; Byeon HK; Oh KH; Baek SK; Kwon SY; Jung KY; Woo JS
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2355-2361. PubMed ID: 30019191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]